Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Forms 3, 4 and 5: Stock Options

BRAINSTORM CELL THERAPEUTICS INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2026-07-24: Reporting owner Pitts Peter Joe; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2026-06-03: Reporting owner Pitts Peter Joe; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
  • 2026-02-26: Reporting owner Bairu Menghisteab; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2026-02-26: Reporting owner Polverino Anthony J.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).

BCLI insiders transactions against the stock price

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.46$0.58$0.74$0.94$1.19$1.512025-09-292026-09-29$0.46$1.25$3.41$9.32$25.47$69.622021-09-292026-09-29$0.46$1.65$5.94$21.44$77.37$279.252016-09-292026-09-29$0.46$1.65$5.94$21.44$77.37$279.252006-09-292026-09-29$0.46$2.04$9.12$40.77$182.28$815.062003-10-072026-09-292006-02-06: 1 award or grant at $112.50 close — STOLICK DAVID2006-02-06: 1 disposition to the issuer at $112.50 close — STOLICK DAVID2006-05-02: 3 award or grants at $117.00 close — STOLICK DAVID, ARBEL IRIT, Drucker Yoram2006-09-17: 1 award or grant at $63.00 close — ARBEL IRIT2006-09-17: 1 disposition to the issuer at $63.00 close — ARBEL IRIT2007-03-21: 3 award or grants at $105.75 close — Drucker Yoram, STOLICK DAVID, ARBEL IRIT2007-07-01: 1 award or grant at $87.75 close — ARBEL IRIT2007-07-16: 1 award or grant at $173.25 close — Lion Moshe2007-08-27: 1 award or grant at $191.25 close — Javitt Jonathan C2007-10-23: 1 award or grant at $195.75 close — Efrati Abraham2007-10-23: 1 tax withholding at $195.75 close — ARBEL IRIT2009-03-16: 1 award or grant at $22.50 close — TAUB MALCOLM S2009-06-29: 2 award or grants at $15.75 close — Efrati Abraham, STOLICK DAVID2009-08-31: 2 award or grants at $40.50 close — Lion Moshe, ARBEL IRIT2009-12-13: 1 award or grant at $47.25 close — ARBEL IRIT2010-02-12: 1 option exercise at $81.00 close — STOLICK DAVID2010-04-13: 1 award or grant at $67.50 close — Israeli Avi2010-06-23: 1 award or grant at $49.50 close — Sossover Liat2010-12-16: 3 award or grants at $45.00 close — ARBEL IRIT, TAUB MALCOLM S, Israeli Avi2011-04-13: 1 award or grant at $65.25 close — Israeli Avi2011-06-27: 7 award or grants at $108.00 close — Harel Adrian, Pinkas Alon, ARBEL IRIT and 1 more2011-08-10: 1 award or grant at $92.25 close — Harel Adrian2012-04-13: 1 award or grant at $54.00 close — Israeli Avi2012-08-01: 7 award or grants at $58.50 close — ARBEL IRIT, Pinkas Alon, Friedman Mordechai and 2 more2013-04-13: 1 award or grant at $54.00 close — Israeli Avi2013-04-19: 3 award or grants at $51.75 close — Friedman Mordechai, Pinkas Alon, ARBEL IRIT2013-12-31: 1 award or grant at $40.50 close — Sossover Liat2014-04-13: 2 award or grants at $60.75 close — Israeli Avi2014-06-06: 1 award or grant at $65.25 close — Yablonka Uri2014-06-09: 1 award or grant at $67.50 close — Fiorino Anthony S.2014-08-15: 4 award or grants at $67.50 close — ARBEL IRIT, Friedman Mordechai, Yablonka Uri and 1 more2015-06-01: 1 award or grant at $55.50 close — ARBEL IRIT2015-07-30: 1 award or grant at $47.55 close — Bibring Yoram2015-08-27: 4 award or grants at $43.50 close — Yablonka Uri, Pinkas Alon, Friedman Mordechai and 1 more2015-09-28: 2 award or grants at $36.75 close — Lebovits Chaim2015-12-01: 1 disposition to the issuer at $41.70 close — Bibring Yoram2015-12-14: 1 option exercise at $38.85 close — Friedman Mordechai2016-06-22: 4 award or grants at $36.60 close — ARBEL IRIT, Friedman Mordechai, Pinkas Alon and 1 more2017-02-26: 1 award or grant at $62.25 close — ARBEL IRIT2017-03-06: 1 award or grant at $59.85 close — Kern Ralph Dr.2017-07-13: 1 award or grant at $67.65 close — ARBEL IRIT2017-07-26: 1 award or grant at $72.45 close — Lebovits Chaim2017-11-10: 2 award or grants at $61.35 close — ARBEL IRIT, Yablonka Uri2017-11-20: 1 award or grant at $60.00 close — Rubin Eyal2018-08-28: 1 award or grant at $59.70 close — Araya Arturo2018-11-30: 2 award or grants at $46.65 close — ARBEL IRIT, Yablonka Uri2019-08-28: 2 option exercises at $55.65 close — ARBEL IRIT2019-09-06: 2 award or grants at $60.60 close — Shah Preetam2019-12-12: 2 award or grants at $58.35 close — Yablonka Uri, ARBEL IRIT2020-03-09: 1 award or grant at $109.95 close — Kern Ralph Dr.2020-04-06: 1 award or grant at $72.15 close — FRENKEL JACOB A2020-06-01: 1 award or grant at $115.05 close — Lindborg Stacy2020-09-08: 1 award or grant at $195.30 close — Waclawski Anthony2020-11-17: 1 purchase at $11,000.00 filed · Value $2.20M — Lindborg Stacy2021-12-10: 3 award or grants at $51.30 close — ARBEL IRIT, FRENKEL JACOB A, Yablonka Uri2021-12-15: 2 award or grants at $49.35 close — Yablonka Uri, ARBEL IRIT2022-04-06: 1 award or grant at $52.35 close — FRENKEL JACOB A2023-05-01: 1 award or grant at $44.85 close — Taylor Kirk2024-06-24: 1 award or grant at $5.70 close — HARTOUNIAN HARTOUN2026-02-26: 6 award or grants at $0.70 filed · Value $756.00K — Bairu Menghisteab, Polverino Anthony J., HARTOUNIAN HARTOUN and 3 more2026-07-24: 1 award or grant at $0.96 close — Pitts Peter Joe

Logarithmic scale. Both lines share the same starting value for the selected range.

Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.

Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2026-07-24Pitts Peter Joe
Director, Officer (Executive Chairman)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+900,000
900,000 owned after
$1.00
exercise price
$0.962026-07-28
2026-06-03
holding as of filing
Pitts Peter Joe
Director
3Stock Option (Right to Buy)
Derivative · Direct
Holding$0.68
exercise price
2026-06-03
2026-02-26Bairu Menghisteab
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+150,000
150,000 owned after
$0.70$0.702026-05-20
2026-02-26Polverino Anthony J.
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+150,000
150,000 owned after
$0.70$0.702026-05-20
2026-02-26HARTOUNIAN HARTOUN
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+225,000
225,000 owned after
$0.70$0.702026-05-20
2026-02-26Lindborg Stacy
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+150,000
150,000 owned after
$0.70$0.702026-05-20
2026-02-26Naor Nir
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+180,000
180,000 owned after
$0.70$0.702026-05-20
2026-02-26Dagher Ibrahim B.
Director
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+225,000
225,000 owned after
$0.70$0.702026-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37